nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—POMC—vagus nerve—pharynx cancer	0.151	0.2	CbGeAlD
Loperamide—POMC—cranial nerve—pharynx cancer	0.115	0.152	CbGeAlD
Loperamide—CALM1—trigeminal nerve—pharynx cancer	0.0438	0.058	CbGeAlD
Loperamide—POMC—neck—pharynx cancer	0.0331	0.0438	CbGeAlD
Loperamide—CALM1—cranial nerve—pharynx cancer	0.0312	0.0413	CbGeAlD
Loperamide—CALM2—ear—pharynx cancer	0.0255	0.0338	CbGeAlD
Loperamide—CALM1—ear—pharynx cancer	0.0254	0.0336	CbGeAlD
Loperamide—POMC—brainstem—pharynx cancer	0.0253	0.0334	CbGeAlD
Loperamide—CACNA1A—brainstem—pharynx cancer	0.0241	0.0319	CbGeAlD
Loperamide—POMC—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0221	0.0904	CbGpPWpGaD
Loperamide—POMC—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0194	0.0793	CbGpPWpGaD
Loperamide—POMC—lymphoid tissue—pharynx cancer	0.0173	0.0229	CbGeAlD
Loperamide—POMC—spinal cord—pharynx cancer	0.0157	0.0208	CbGeAlD
Loperamide—POMC—head—pharynx cancer	0.014	0.0185	CbGeAlD
Loperamide—CACNA1A—head—pharynx cancer	0.0133	0.0176	CbGeAlD
Loperamide—POMC—Biological oxidations—CNDP2—pharynx cancer	0.013	0.0531	CbGpPWpGaD
Loperamide—POMC—Biological oxidations—ADH7—pharynx cancer	0.0117	0.048	CbGpPWpGaD
Loperamide—CALM2—mouth—pharynx cancer	0.0106	0.014	CbGeAlD
Loperamide—CALM1—mouth—pharynx cancer	0.0105	0.0139	CbGeAlD
Loperamide—POMC—Biological oxidations—ADH1B—pharynx cancer	0.0103	0.0421	CbGpPWpGaD
Loperamide—CYP2D6—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0102	0.0418	CbGpPWpGaD
Loperamide—OPRM1—brainstem—pharynx cancer	0.00951	0.0126	CbGeAlD
Loperamide—POMC—Syndecan-3-mediated signaling events—EGFR—pharynx cancer	0.00945	0.0386	CbGpPWpGaD
Loperamide—CALM3—parotid gland—pharynx cancer	0.00936	0.0124	CbGeAlD
Loperamide—CALM2—neck—pharynx cancer	0.00903	0.012	CbGeAlD
Loperamide—CALM1—neck—pharynx cancer	0.00899	0.0119	CbGeAlD
Loperamide—CALM3—saliva-secreting gland—pharynx cancer	0.00897	0.0119	CbGeAlD
Loperamide—CYP2D6—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.00895	0.0366	CbGpPWpGaD
Loperamide—OPRD1—head—pharynx cancer	0.0077	0.0102	CbGeAlD
Loperamide—OPRK1—head—pharynx cancer	0.00739	0.00978	CbGeAlD
Loperamide—CALM2—parotid gland—pharynx cancer	0.00735	0.00973	CbGeAlD
Loperamide—CALM2—saliva-secreting gland—pharynx cancer	0.00704	0.00932	CbGeAlD
Loperamide—CALM1—saliva-secreting gland—pharynx cancer	0.00701	0.00928	CbGeAlD
Loperamide—CALM3—trachea—pharynx cancer	0.00692	0.00916	CbGeAlD
Loperamide—CALM2—brainstem—pharynx cancer	0.0069	0.00913	CbGeAlD
Loperamide—CALM1—brainstem—pharynx cancer	0.00687	0.00909	CbGeAlD
Loperamide—CYP3A4—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.00667	0.0273	CbGpPWpGaD
Loperamide—CALM2—epithelium—pharynx cancer	0.00614	0.00813	CbGeAlD
Loperamide—CALM1—epithelium—pharynx cancer	0.00612	0.00809	CbGeAlD
Loperamide—OPRM1—spinal cord—pharynx cancer	0.00591	0.00782	CbGeAlD
Loperamide—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.00585	0.0239	CbGpPWpGaD
Loperamide—CALM3—spinal cord—pharynx cancer	0.00546	0.00723	CbGeAlD
Loperamide—CALM2—trachea—pharynx cancer	0.00543	0.00719	CbGeAlD
Loperamide—CALM1—trachea—pharynx cancer	0.00541	0.00716	CbGeAlD
Loperamide—OPRM1—head—pharynx cancer	0.00525	0.00695	CbGeAlD
Loperamide—CALM2—lymphoid tissue—pharynx cancer	0.00473	0.00626	CbGeAlD
Loperamide—CALM1—lymphoid tissue—pharynx cancer	0.00471	0.00623	CbGeAlD
Loperamide—CALM2—spinal cord—pharynx cancer	0.00429	0.00568	CbGeAlD
Loperamide—CALM1—spinal cord—pharynx cancer	0.00427	0.00565	CbGeAlD
Loperamide—CYP2B6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00413	0.0169	CbGpPWpGaD
Loperamide—CALM2—head—pharynx cancer	0.00381	0.00505	CbGeAlD
Loperamide—CYP2D6—brainstem—pharynx cancer	0.00381	0.00504	CbGeAlD
Loperamide—CALM1—head—pharynx cancer	0.0038	0.00502	CbGeAlD
Loperamide—CYP2B6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00363	0.0148	CbGpPWpGaD
Loperamide—CALM3—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—CD79A—pharynx cancer	0.00359	0.0147	CbGpPWpGaD
Loperamide—CYP2B6—lymphoid tissue—pharynx cancer	0.00352	0.00466	CbGeAlD
Loperamide—CYP2C8—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0035	0.0143	CbGpPWpGaD
Loperamide—CALM2—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—CD79A—pharynx cancer	0.00347	0.0142	CbGpPWpGaD
Loperamide—CALM1—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—CD79A—pharynx cancer	0.00347	0.0142	CbGpPWpGaD
Loperamide—CALM3—lymph node—pharynx cancer	0.0034	0.0045	CbGeAlD
Loperamide—POMC—Metabolism of proteins—B4GALT5—pharynx cancer	0.00326	0.0134	CbGpPWpGaD
Loperamide—CYP2C8—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00307	0.0126	CbGpPWpGaD
Loperamide—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00287	0.0118	CbGpPWpGaD
Loperamide—CYP2B6—head—pharynx cancer	0.00283	0.00375	CbGeAlD
Loperamide—CALM2—lymph node—pharynx cancer	0.00267	0.00353	CbGeAlD
Loperamide—POMC—Glucocorticoid receptor regulatory network—TP53—pharynx cancer	0.00267	0.0109	CbGpPWpGaD
Loperamide—CALM1—lymph node—pharynx cancer	0.00266	0.00352	CbGeAlD
Loperamide—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00252	0.0103	CbGpPWpGaD
Loperamide—ABCB1—epithelium—pharynx cancer	0.00244	0.00323	CbGeAlD
Loperamide—CYP2B6—Biological oxidations—CNDP2—pharynx cancer	0.00243	0.00994	CbGpPWpGaD
Loperamide—POMC—Metabolism—CNDP2—pharynx cancer	0.00222	0.00908	CbGpPWpGaD
Loperamide—CYP2B6—Biological oxidations—ADH7—pharynx cancer	0.0022	0.00899	CbGpPWpGaD
Loperamide—ABCB1—trachea—pharynx cancer	0.00216	0.00286	CbGeAlD
Loperamide—CYP2D6—head—pharynx cancer	0.00211	0.00279	CbGeAlD
Loperamide—CALM3—BCR signaling pathway—CD79A—pharynx cancer	0.00209	0.00854	CbGpPWpGaD
Loperamide—CYP2C8—Biological oxidations—CNDP2—pharynx cancer	0.00206	0.00841	CbGpPWpGaD
Loperamide—CALM1—BCR signaling pathway—CD79A—pharynx cancer	0.00202	0.00826	CbGpPWpGaD
Loperamide—CALM2—BCR signaling pathway—CD79A—pharynx cancer	0.00202	0.00826	CbGpPWpGaD
Loperamide—POMC—Metabolism—ADH7—pharynx cancer	0.00201	0.00822	CbGpPWpGaD
Loperamide—CYP2B6—Biological oxidations—ADH1B—pharynx cancer	0.00193	0.00788	CbGpPWpGaD
Loperamide—CACNA1A—Metabolism—CNDP2—pharynx cancer	0.00192	0.00785	CbGpPWpGaD
Loperamide—ABCB1—lymphoid tissue—pharynx cancer	0.00188	0.00249	CbGeAlD
Loperamide—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00188	0.00769	CbGpPWpGaD
Loperamide—CYP2C8—Biological oxidations—ADH7—pharynx cancer	0.00186	0.00761	CbGpPWpGaD
Loperamide—POMC—Metabolism—ADH1B—pharynx cancer	0.00176	0.0072	CbGpPWpGaD
Loperamide—CACNA1A—Metabolism—ADH7—pharynx cancer	0.00174	0.0071	CbGpPWpGaD
Loperamide—ABCB1—spinal cord—pharynx cancer	0.0017	0.00226	CbGeAlD
Loperamide—CYP2D6—Biological oxidations—CNDP2—pharynx cancer	0.00169	0.00691	CbGpPWpGaD
Loperamide—POMC—Metabolism—B4GALT5—pharynx cancer	0.00168	0.00688	CbGpPWpGaD
Loperamide—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00165	0.00674	CbGpPWpGaD
Loperamide—CYP2C8—Biological oxidations—ADH1B—pharynx cancer	0.00163	0.00667	CbGpPWpGaD
Loperamide—CYP2D6—Biological oxidations—ADH7—pharynx cancer	0.00153	0.00625	CbGpPWpGaD
Loperamide—CACNA1A—Metabolism—ADH1B—pharynx cancer	0.00152	0.00623	CbGpPWpGaD
Loperamide—ABCB1—head—pharynx cancer	0.00152	0.00201	CbGeAlD
Loperamide—CACNA1A—Metabolism—B4GALT5—pharynx cancer	0.00145	0.00595	CbGpPWpGaD
Loperamide—CYP2D6—Biological oxidations—ADH1B—pharynx cancer	0.00134	0.00548	CbGpPWpGaD
Loperamide—CALM3—Carbohydrate metabolism—B4GALT5—pharynx cancer	0.00129	0.00528	CbGpPWpGaD
Loperamide—CALM2—Carbohydrate metabolism—B4GALT5—pharynx cancer	0.00125	0.00511	CbGpPWpGaD
Loperamide—CALM1—Carbohydrate metabolism—B4GALT5—pharynx cancer	0.00125	0.00511	CbGpPWpGaD
Loperamide—CALM3—EGFR interacts with phospholipase C-gamma—EGFR—pharynx cancer	0.00114	0.00468	CbGpPWpGaD
Loperamide—CALM3—PLCG1 events in ERBB2 signaling—EGFR—pharynx cancer	0.00112	0.00457	CbGpPWpGaD
Loperamide—CALM2—EGFR interacts with phospholipase C-gamma—EGFR—pharynx cancer	0.00111	0.00452	CbGpPWpGaD
Loperamide—CALM1—EGFR interacts with phospholipase C-gamma—EGFR—pharynx cancer	0.00111	0.00452	CbGpPWpGaD
Loperamide—CYP3A4—Biological oxidations—CNDP2—pharynx cancer	0.0011	0.00452	CbGpPWpGaD
Loperamide—CALM2—PLCG1 events in ERBB2 signaling—EGFR—pharynx cancer	0.00108	0.00442	CbGpPWpGaD
Loperamide—CALM1—PLCG1 events in ERBB2 signaling—EGFR—pharynx cancer	0.00108	0.00442	CbGpPWpGaD
Loperamide—ABCB1—lymph node—pharynx cancer	0.00106	0.0014	CbGeAlD
Loperamide—CYP3A4—Biological oxidations—ADH7—pharynx cancer	0.000998	0.00408	CbGpPWpGaD
Loperamide—CALM3—B Cell Activation—CD79A—pharynx cancer	0.000888	0.00363	CbGpPWpGaD
Loperamide—CYP3A4—Biological oxidations—ADH1B—pharynx cancer	0.000875	0.00358	CbGpPWpGaD
Loperamide—CALM2—B Cell Activation—CD79A—pharynx cancer	0.000859	0.00351	CbGpPWpGaD
Loperamide—CALM1—B Cell Activation—CD79A—pharynx cancer	0.000859	0.00351	CbGpPWpGaD
Loperamide—CALM3—Alzheimers Disease—TP53—pharynx cancer	0.0005	0.00205	CbGpPWpGaD
Loperamide—CALM2—Alzheimers Disease—TP53—pharynx cancer	0.000484	0.00198	CbGpPWpGaD
Loperamide—CALM1—Alzheimers Disease—TP53—pharynx cancer	0.000484	0.00198	CbGpPWpGaD
Loperamide—CALM3—ErbB1 downstream signaling—EGFR—pharynx cancer	0.000475	0.00194	CbGpPWpGaD
Loperamide—CALM2—ErbB1 downstream signaling—EGFR—pharynx cancer	0.000459	0.00188	CbGpPWpGaD
Loperamide—CALM1—ErbB1 downstream signaling—EGFR—pharynx cancer	0.000459	0.00188	CbGpPWpGaD
Loperamide—POMC—Signaling by GPCR—EGFR—pharynx cancer	0.000425	0.00174	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—CNDP2—pharynx cancer	0.000415	0.0017	CbGpPWpGaD
Loperamide—CALM3—Metabolism—CNDP2—pharynx cancer	0.000404	0.00165	CbGpPWpGaD
Loperamide—CALM1—Metabolism—CNDP2—pharynx cancer	0.000391	0.0016	CbGpPWpGaD
Loperamide—CALM2—Metabolism—CNDP2—pharynx cancer	0.000391	0.0016	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—ADH7—pharynx cancer	0.000376	0.00154	CbGpPWpGaD
Loperamide—CALM3—Disease—B4GALT5—pharynx cancer	0.000366	0.0015	CbGpPWpGaD
Loperamide—CALM3—Metabolism—ADH7—pharynx cancer	0.000366	0.0015	CbGpPWpGaD
Loperamide—CALM3—Downstream signaling of activated FGFR—EGFR—pharynx cancer	0.000359	0.00147	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—CD79A—pharynx cancer	0.000358	0.00146	CbGpPWpGaD
Loperamide—CALM1—Disease—B4GALT5—pharynx cancer	0.000354	0.00145	CbGpPWpGaD
Loperamide—CALM2—Disease—B4GALT5—pharynx cancer	0.000354	0.00145	CbGpPWpGaD
Loperamide—CALM2—Metabolism—ADH7—pharynx cancer	0.000354	0.00145	CbGpPWpGaD
Loperamide—CALM1—Metabolism—ADH7—pharynx cancer	0.000354	0.00145	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—CNDP2—pharynx cancer	0.000352	0.00144	CbGpPWpGaD
Loperamide—CALM2—Downstream signaling of activated FGFR—EGFR—pharynx cancer	0.000347	0.00142	CbGpPWpGaD
Loperamide—CALM1—Downstream signaling of activated FGFR—EGFR—pharynx cancer	0.000347	0.00142	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—CD79A—pharynx cancer	0.000346	0.00142	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—CD79A—pharynx cancer	0.000346	0.00142	CbGpPWpGaD
Loperamide—CALM3—Downstream signal transduction—EGFR—pharynx cancer	0.000337	0.00138	CbGpPWpGaD
Loperamide—CALM3—Signaling by FGFR—EGFR—pharynx cancer	0.000335	0.00137	CbGpPWpGaD
Loperamide—CALM3—Signaling by ERBB2—EGFR—pharynx cancer	0.000334	0.00137	CbGpPWpGaD
Loperamide—CALM3—DAP12 signaling—EGFR—pharynx cancer	0.000332	0.00136	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—ADH1B—pharynx cancer	0.000329	0.00135	CbGpPWpGaD
Loperamide—CALM2—Downstream signal transduction—EGFR—pharynx cancer	0.000326	0.00133	CbGpPWpGaD
Loperamide—CALM1—Downstream signal transduction—EGFR—pharynx cancer	0.000326	0.00133	CbGpPWpGaD
Loperamide—CALM2—Signaling by FGFR—EGFR—pharynx cancer	0.000324	0.00133	CbGpPWpGaD
Loperamide—CALM1—Signaling by FGFR—EGFR—pharynx cancer	0.000324	0.00133	CbGpPWpGaD
Loperamide—CALM1—Signaling by ERBB2—EGFR—pharynx cancer	0.000323	0.00132	CbGpPWpGaD
Loperamide—CALM2—Signaling by ERBB2—EGFR—pharynx cancer	0.000323	0.00132	CbGpPWpGaD
Loperamide—CALM2—DAP12 signaling—EGFR—pharynx cancer	0.000321	0.00131	CbGpPWpGaD
Loperamide—CALM1—DAP12 signaling—EGFR—pharynx cancer	0.000321	0.00131	CbGpPWpGaD
Loperamide—CALM3—Metabolism—ADH1B—pharynx cancer	0.000321	0.00131	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—CCND1—pharynx cancer	0.00032	0.00131	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—ADH7—pharynx cancer	0.000318	0.0013	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—B4GALT5—pharynx cancer	0.000315	0.00129	CbGpPWpGaD
Loperamide—CALM3—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000312	0.00128	CbGpPWpGaD
Loperamide—CALM3—DAP12 interactions—EGFR—pharynx cancer	0.000312	0.00128	CbGpPWpGaD
Loperamide—CALM3—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000312	0.00128	CbGpPWpGaD
Loperamide—CALM2—Metabolism—ADH1B—pharynx cancer	0.00031	0.00127	CbGpPWpGaD
Loperamide—CALM1—Metabolism—ADH1B—pharynx cancer	0.00031	0.00127	CbGpPWpGaD
Loperamide—CALM3—Signaling by EGFR—EGFR—pharynx cancer	0.00031	0.00127	CbGpPWpGaD
Loperamide—CALM3—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000307	0.00126	CbGpPWpGaD
Loperamide—CALM3—Metabolism—B4GALT5—pharynx cancer	0.000306	0.00125	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CNDP2—pharynx cancer	0.000306	0.00125	CbGpPWpGaD
Loperamide—CALM3—Signaling by PDGF—EGFR—pharynx cancer	0.000306	0.00125	CbGpPWpGaD
Loperamide—CALM1—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000302	0.00124	CbGpPWpGaD
Loperamide—CALM2—DAP12 interactions—EGFR—pharynx cancer	0.000302	0.00124	CbGpPWpGaD
Loperamide—CALM2—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000302	0.00124	CbGpPWpGaD
Loperamide—CALM1—DAP12 interactions—EGFR—pharynx cancer	0.000302	0.00124	CbGpPWpGaD
Loperamide—CALM1—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000302	0.00124	CbGpPWpGaD
Loperamide—CALM2—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000302	0.00124	CbGpPWpGaD
Loperamide—CALM2—Signaling by EGFR—EGFR—pharynx cancer	0.0003	0.00123	CbGpPWpGaD
Loperamide—CALM1—Signaling by EGFR—EGFR—pharynx cancer	0.0003	0.00123	CbGpPWpGaD
Loperamide—CALM1—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000297	0.00121	CbGpPWpGaD
Loperamide—CALM2—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000297	0.00121	CbGpPWpGaD
Loperamide—CALM2—Metabolism—B4GALT5—pharynx cancer	0.000296	0.00121	CbGpPWpGaD
Loperamide—CALM1—Metabolism—B4GALT5—pharynx cancer	0.000296	0.00121	CbGpPWpGaD
Loperamide—CALM1—Signaling by PDGF—EGFR—pharynx cancer	0.000296	0.00121	CbGpPWpGaD
Loperamide—CALM2—Signaling by PDGF—EGFR—pharynx cancer	0.000296	0.00121	CbGpPWpGaD
Loperamide—CALM3—B Cell Activation—EGFR—pharynx cancer	0.000289	0.00118	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CNDP2—pharynx cancer	0.000289	0.00118	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.000284	0.00116	CbGpPWpGaD
Loperamide—CALM2—B Cell Activation—EGFR—pharynx cancer	0.00028	0.00114	CbGpPWpGaD
Loperamide—CALM1—B Cell Activation—EGFR—pharynx cancer	0.00028	0.00114	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—ADH1B—pharynx cancer	0.000279	0.00114	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—ADH7—pharynx cancer	0.000277	0.00113	CbGpPWpGaD
Loperamide—CALM3—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000277	0.00113	CbGpPWpGaD
Loperamide—CALM2—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000268	0.0011	CbGpPWpGaD
Loperamide—CALM1—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000268	0.0011	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—B4GALT5—pharynx cancer	0.000266	0.00109	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—ADH7—pharynx cancer	0.000261	0.00107	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—EGFR—pharynx cancer	0.000251	0.00103	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—ADH1B—pharynx cancer	0.000243	0.000994	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—B4GALT5—pharynx cancer	0.000232	0.00095	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—ADH1B—pharynx cancer	0.000229	0.000937	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000223	0.000912	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—B4GALT5—pharynx cancer	0.000219	0.000895	CbGpPWpGaD
Loperamide—CALM3—Immune System—CD79A—pharynx cancer	0.000217	0.000888	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—EGFR—pharynx cancer	0.000213	0.000871	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—TP53—pharynx cancer	0.000211	0.000863	CbGpPWpGaD
Loperamide—CALM1—Immune System—CD79A—pharynx cancer	0.00021	0.000859	CbGpPWpGaD
Loperamide—CALM2—Immune System—CD79A—pharynx cancer	0.00021	0.000859	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—EGFR—pharynx cancer	0.000206	0.000843	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—EGFR—pharynx cancer	0.000206	0.000843	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—CDH1—pharynx cancer	0.000199	0.000816	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—CDH1—pharynx cancer	0.000193	0.000789	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—CDH1—pharynx cancer	0.000193	0.000789	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CNDP2—pharynx cancer	0.000189	0.000772	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000187	0.000766	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ADH7—pharynx cancer	0.000171	0.000698	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—EGFR—pharynx cancer	0.000169	0.00069	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ADH1B—pharynx cancer	0.00015	0.000612	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—EGFR—pharynx cancer	0.000148	0.000605	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—B4GALT5—pharynx cancer	0.000143	0.000585	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—CCND1—pharynx cancer	0.000127	0.00052	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—EGFR—pharynx cancer	0.000125	0.000512	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—EGFR—pharynx cancer	0.000121	0.000497	CbGpPWpGaD
Loperamide—CALM3—Immune System—CDH1—pharynx cancer	0.000121	0.000495	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—EGFR—pharynx cancer	0.000117	0.000481	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—EGFR—pharynx cancer	0.000117	0.000481	CbGpPWpGaD
Loperamide—CALM1—Immune System—CDH1—pharynx cancer	0.000117	0.000479	CbGpPWpGaD
Loperamide—CALM2—Immune System—CDH1—pharynx cancer	0.000117	0.000479	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—EGFR—pharynx cancer	0.000117	0.000477	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—TP53—pharynx cancer	0.000113	0.000463	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—EGFR—pharynx cancer	0.000113	0.000461	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—EGFR—pharynx cancer	0.000113	0.000461	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—CCND1—pharynx cancer	0.000111	0.000456	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—TP53—pharynx cancer	0.00011	0.000448	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—TP53—pharynx cancer	0.00011	0.000448	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—EGFR—pharynx cancer	9.97e-05	0.000408	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—CCND1—pharynx cancer	9.41e-05	0.000385	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—EGFR—pharynx cancer	8.74e-05	0.000358	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TP53—pharynx cancer	8.37e-05	0.000342	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—EGFR—pharynx cancer	7.74e-05	0.000317	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—EGFR—pharynx cancer	7.49e-05	0.000306	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—EGFR—pharynx cancer	7.49e-05	0.000306	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—EGFR—pharynx cancer	7.39e-05	0.000302	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TP53—pharynx cancer	7.34e-05	0.0003	CbGpPWpGaD
Loperamide—CALM3—Immune System—EGFR—pharynx cancer	7.07e-05	0.000289	CbGpPWpGaD
Loperamide—CALM2—Immune System—EGFR—pharynx cancer	6.84e-05	0.00028	CbGpPWpGaD
Loperamide—CALM1—Immune System—EGFR—pharynx cancer	6.84e-05	0.00028	CbGpPWpGaD
Loperamide—CALM3—Disease—EGFR—pharynx cancer	6.53e-05	0.000267	CbGpPWpGaD
Loperamide—CALM2—Disease—EGFR—pharynx cancer	6.32e-05	0.000258	CbGpPWpGaD
Loperamide—CALM1—Disease—EGFR—pharynx cancer	6.32e-05	0.000258	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TP53—pharynx cancer	6.2e-05	0.000254	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CCND1—pharynx cancer	5.83e-05	0.000238	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CCND1—pharynx cancer	5.64e-05	0.000231	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CCND1—pharynx cancer	5.64e-05	0.000231	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—EGFR—pharynx cancer	4.57e-05	0.000187	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—EGFR—pharynx cancer	4.42e-05	0.000181	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—EGFR—pharynx cancer	4.42e-05	0.000181	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TP53—pharynx cancer	3.84e-05	0.000157	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TP53—pharynx cancer	3.71e-05	0.000152	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TP53—pharynx cancer	3.71e-05	0.000152	CbGpPWpGaD
